Switzerland Pharmaceuticals

Cosmo Pharmaceuticals NV (COPN)

Track

Track

Cosmo Pharmaceuticals NV recorded no insider trading activity during the past three months. The most recent transactions occurred in May 2026, consisting exclusively of sales. Prior to this period, the company saw a mix of divestments and a single purchase in March 2026. All reported movements predate the current quarter.
Ticker: COPN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cosmo Pharmaceuticals NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Non-Executive Director
Transaction date
Sale
Price
469.83
Quantity 28,802
Value CHF577,396
Non-Executive Director
Transaction date
Sale
Price
129.79
Quantity 53,872
Value CHF4,252,740
Non-Executive Director
Transaction date
Sale
Price
114.70
Quantity 92,613
Value CHF2,437,987
Non-Executive Director
Transaction date
Sale
Price
99.00
Quantity 4,000
Value CHF396,000
Non-Executive Director
Transaction date
Sale
Price
98.78
Quantity 10,500
Value CHF1,037,148
Non-Executive Director
Transaction date
Sale
Price
97.93
Quantity 7,500
Value CHF734,497
Non-Executive Director
Transaction date
Sale
Price
98.36
Quantity 8,500
Value CHF836,102
Non-Executive Director
Transaction date
Sale
Price
102.58
Quantity 30,050
Value CHF3,082,529
Non-Executive Director
Transaction date
Purchase
Price
92.00
Quantity 2,886
Value CHF265,512
Executive Director / Officer
Transaction date
Sale
Price
114.00
Quantity 1,000
Value CHF114,000
Executive Director / Officer
Transaction date
Sale
Price
109.80
Quantity 2,000
Value CHF219,600
Executive Director / Officer
Transaction date
Sale
Price
110.50
Quantity 1,000
Value CHF110,500
Executive Director / Officer
Transaction date
Sale
Price
110.40
Quantity 100
Value CHF11,040
Executive Director / Officer
Transaction date
Sale
Price
107.20
Quantity 1,000
Value CHF107,200
Executive Director / Officer
Transaction date
Sale
Price
107.00
Quantity 500
Value CHF53,500
Executive Director / Officer
Transaction date
Sale
Price
106.40
Quantity 500
Value CHF53,200
Executive Director / Officer
Transaction date
Sale
Price
107.00
Quantity 1,000
Value CHF107,000
Executive Director / Officer
Transaction date
Sale
Price
108.50
Quantity 1,000
Value CHF108,500
Executive Director / Officer
Transaction date
Sale
Price
108.30
Quantity 1,000
Value CHF108,300
Executive Director / Officer
Transaction date
Sale
Price
107.00
Quantity 155
Value CHF16,585
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-11 S Sale Non-Executive Director
28,802
469.83
CHF577,396 		28,802 469.83 CHF577,396
2026-05-04 2026-05-04 S Sale Non-Executive Director
53,872
129.79
CHF4,252,740 		53,872 129.79 CHF4,252,740
2026-05-04 2026-05-04 S Sale Non-Executive Director
92,613
114.70
CHF2,437,987 		92,613 114.70 CHF2,437,987
2026-04-21 2026-04-21 S Sale Non-Executive Director
4,000
99.00
CHF396,000 		4,000 99.00 CHF396,000
2026-04-20 2026-04-20 S Sale Non-Executive Director
10,500
98.78
CHF1,037,148 		10,500 98.78 CHF1,037,148
2026-04-17 2026-04-17 S Sale Non-Executive Director
7,500
97.93
CHF734,497 		7,500 97.93 CHF734,497
2026-04-16 2026-04-16 S Sale Non-Executive Director
8,500
98.36
CHF836,102 		8,500 98.36 CHF836,102
2026-04-15 2026-04-15 S Sale Non-Executive Director
30,050
102.58
CHF3,082,529 		30,050 102.58 CHF3,082,529
2026-03-09 2026-03-09 B Purchase Non-Executive Director
2,886
92.00
CHF265,512 		2,886 92.00 CHF265,512
2026-01-21 2026-01-21 S Sale Executive Director / Officer
1,000
114.00
CHF114,000 		1,000 114.00 CHF114,000
2026-01-16 2026-01-16 S Sale Executive Director / Officer
2,000
109.80
CHF219,600 		2,000 109.80 CHF219,600
2026-01-16 2026-01-16 S Sale Executive Director / Officer
1,000
110.50
CHF110,500 		1,000 110.50 CHF110,500
2026-01-16 2026-01-16 S Sale Executive Director / Officer
100
110.40
CHF11,040 		100 110.40 CHF11,040
2026-01-15 2026-01-15 S Sale Executive Director / Officer
1,000
107.20
CHF107,200 		1,000 107.20 CHF107,200
2026-01-14 2026-01-14 S Sale Executive Director / Officer
500
107.00
CHF53,500 		500 107.00 CHF53,500
2026-01-14 2026-01-14 S Sale Executive Director / Officer
500
106.40
CHF53,200 		500 106.40 CHF53,200
2026-01-13 2026-01-13 S Sale Executive Director / Officer
1,000
107.00
CHF107,000 		1,000 107.00 CHF107,000
2026-01-07 2026-01-07 S Sale Executive Director / Officer
1,000
108.50
CHF108,500 		1,000 108.50 CHF108,500
2026-01-06 2026-01-06 S Sale Executive Director / Officer
1,000
108.30
CHF108,300 		1,000 108.30 CHF108,300
2026-01-05 2026-01-05 S Sale Executive Director / Officer
155
107.00
CHF16,585 		155 107.00 CHF16,585
Explore more

More insider trading research around Cosmo Pharmaceuticals NV

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index